Skip to content

Validation study about priming effect and the day after day revelation in an artifical exposure chamber(OHIO Chamber).

Validation study about priming effect and the day after day revelation in an artifical exposure chamber(OHIO Chamber). - Validation study about priming effect and the day after day revelation in an artifical exposure chamber(OHIO Chamber).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010657
Enrollment
28
Registered
2013-05-07
Start date
2013-05-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cedar Pollinosis

Interventions

14 subjects receive cedar pollen exposure in continuation (2hours,4hours,3hours or 2hours,6hours,4hours) for three days. The one week later, 14 subjects receive cedar pollen exposure equally in two d

Sponsors

Samoncho Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)CAPRAST score against Japanese cedar pollen over class 2 within the last 2 years. 2)Patient whom the nose symptom that was apparent to the cedar pollen scattering period this year developed in. 3)Written informed concent is required.

Exclusion criteria

Exclusion criteria: 1)Patients with mucosal lesion of the nose and eyes. 2)Patients who received steroid injections within 6 months. 3) 4)Patients with respiratory disease such as asthma. 5)Patients with past history of anaphylaxis. 6)Patients who have receiving immunotherapy. 7)Patients who were judged to be unsuitable for patient enrollment by their doctor.

Design outcomes

Primary

MeasureTime frame
Symptoms score (Nasal)

Secondary

MeasureTime frame
1)Nasal secretion volume 2)Number of sneezing 3)Occurrence time of first nasal symptoms 4)Bitterness of the symptom(VAS)

Countries

Japan

Contacts

Public ContactSatoko Shimizu

Tokyo Reserch Center of Clinical Pharmacology co.,ltd. Customer Relations Dept.

s-shimizu@trcp.co.jp03-5366-3454

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026